While the importance of epistasis is well established, specific gene-gene interactions have rarely been identified in human genome-wide association studies (GWAS), mainly due to low power associated with such interaction tests. In this chapter, we integrate biological knowledge and human GWAS data to reveal epistatic interactions underlying quantitative lipid traits, which are major risk factors for coronary artery disease. To increase power to detect interactions, we only tested pairs of SNPs filtered by prior biological knowledge, including GWAS results, protein-protein interactions (PPIs), and pathway information. Using published GWAS and 9,713 European Americans (EA) from the Atherosclerosis Risk in Communities (ARIC) study, we identified an interaction between HMGCR and LIPC affecting high-density lipoprotein cholesterol (HDL-C) levels. We then validated this interaction in additional multiethnic cohorts from ARIC, the Framingham Heart Study, and the Multi-Ethnic Study of Atherosclerosis. Both HMGCR and LIPC are involved in the metabolism of lipids and lipoproteins, and LIPC itself has been marginally associated with HDL-C. Furthermore, no significant interaction was detected using PPI and pathway information, mainly due to the stringent significance level required after correcting for the large number of tests conducted. These results suggest the potential of biological knowledge-driven approaches to detect epistatic interactions in human GWAS, which may hold the key to exploring the role gene-gene interactions play in connecting genotypes and complex phenotypes in future GWAS.
Introduction
As of June 2013, over 1,638 publications and 10,859 single nucleotide polymorphisms (SNPs) have been included in the catalog of human genome-wide association studies (GWAS) [1] . Although these SNPs are significantly associated with human diseases and traits, most of them have small effects that, in aggregate, account for only a moderate proportion of heritable variance [2] [3] [4] [5] [6] . Four lipid traits, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) levels, are among the most important risk factors for coronary heart disease. Recently, meta-analyses of many GWAS, with a combined sample size of up to 100,000, have detected hundreds of loci associated with levels of these four lipids [7, 8] . However, these loci collectively only explain 25-30 % of heritable variance of each lipid [7, 8] . Many hypotheses have been offered to explain the missing heritability, including rare and structural variants, gene-environment interactions, epigenetics, and complex inheritance [2] [3] [4] [5] . The missing heritability may also be partially attributed to epistatic or gene-gene interactions [9] [10] [11] . Here, we seek to identify examples of pairwise SNP by SNP interaction effects on any of the four lipid levels in this study.
Since Bateson's first discovery in 1905 that some genes suppress the effects of other genes [12] , researchers have been investigating the effect of epistasis to better understand the complex relationships between genotypes and phenotypes. Studies of model organisms suggested epistasis or gene-gene interactions are a common phenomenon [13] [14] [15] [16] , and a number of gene-gene interactions have been reported in gene mapping studies in animals, plants, and other model organisms [17] [18] [19] [20] . However, gene-gene interactions have proven difficult to find in humans [21, 22] , mainly due to low statistical power caused by the small effect size, the low minor genotype frequency of the multiple-SNP combinations, the large combinatorial number of interaction tests required [14, 23] , and the lack of control over environmental conditions. Hence, to improve power and enable detection of gene-gene interactions in human GWAS, many approaches have been developed to prioritize candidate genes or SNPs using biological knowledge from established GWAS hits [6, 24] , protein-protein interactions (PPIs) [25, 26] , and pathway information [27] .
Tests of gene-gene interactions are not as powerful as tests of single-marker association, so a judicious strategy is essential for successful epistasis analyses in human GWAS [11, 14, 15] . One fundamental limitation to the analysis of epistasis is that the statistical power of each particular test can be easily eroded by the performance of vast numbers of pairwise or higher-order interaction tests. In order to achieve similar success for interaction analyses as one obtains with single-marker tests in GWAS, we are limited to performing a similar number of tests (~1 million), assuming the nominal per-test power to detect interaction is the same as that of a single-marker association test. This limitation prevents us from conducting an inclusive all-by-all interaction analysis in current human GWAS, which typically examines millions of SNPs. If one were to attempt all-by-all epistasis tests, the result is such reduced power that only the most exceptionally strong interactions could be detected. Therefore, we recommend epistasis analysis be done on a reduced number of SNPs, using prior biological knowledge as the simplest way to restrict SNP numbers. The selection of candidate genes or SNPs can be based on any factor(s) that the biologist or medical practitioner chooses. So long as the gene choice is not based on the tests of interactions itself, winnowing down the gene set will not inflate the type I error and can increase the power when the underlying interactions are enriched between candidate genes or SNPs. Criteria such as SNP density, local linkage disequilibrium (LD), and data quality can further supplement primary knowledge of gene function, pathway position, connectedness to networks, etc. in selecting genes.
We illustrate the biological knowledge-driven approach with examples from analyses of large consortium cohort studies of cardiovascular disease [6] . We tested for pairwise SNP by SNP epistatic interactions affecting the level of four lipids, TC, LDL-C, TG, and HDL-C, based on prior knowledge of published GWAS hits, PPIs, and pathway information. Based on GWAS hits, we detected an interaction between HMGCR and a locus upstream of LIPC in their effect on HDL-C levels in the discovery data set from the Atherosclerosis Risk in Communities (ARIC) study. Using a locus-based replication procedure, we validated this interaction in cohorts from the Framingham Heart Study (FHS) and from the Multi-Ethnic Study of Atherosclerosis (MESA). In summary, a biological, knowledge-driven approach might be crucial to the detection of epistatic interactions underlying complex traits and diseases in human GWAS.
Methods and Results
Data sets from three GWAS were considered here, the Atherosclerosis Risk in Communities (ARIC) study, the Framingham Heart Study (FHS), and the Multi-Ethnic Study of Atherosclerosis (MESA). The ARIC study is a multicenter prospective investigation of atherosclerotic disease [28] . This analysis included 9,713 European Americans (EAs) in the discovery study and 3,207 African American (AA) individuals in the validation study. The FHS is a prospective cohort study to evaluate cardiovascular disease (CVD) risk factors, which has been described in detail previously [29] . This analysis included 6,575 EA subjects in the validation study, while accounting for familial relatedness (see Subheading 2.4 below). MESA is a prospective cohort study of individuals aged 45-84 years without clinical CVD recruited from 6 US centers [30] , which is designed to study the characteristics of subclinical CVD and its progression. Participants of MESA self-reported their race or ethnicity group as EA, AA, Chinese American, or Hispanic American (HA). In total 2,685 EA, 2,588 AA, and 2,174 HA individuals were included in the validation. All of the included subjects from the three GWAS studies have both genotypic and phenotypic (lipid) measurements available, as described in the following sections.
Descriptions of GWAS Data
Genotyping of samples was obtained from the ARIC and MESA studies by Affymetrix 6.0 SNP arrays. Affymetrix 6.0 SNP array genotyping of MESA samples and Affymetrix 500K SNP array genotyping of FHS samples were obtained from dbGaP (MESA SHARe, downloaded in May 2011; Framingham Cohort, downloaded in April 2010) [31] . Standard quality control (QC) filters were applied across each of the samples and SNPs, including (1) exclusion of subjects with >10 % missing data; (2) removing SNPs with call rates <90 %; (3) removing SNPs with minor allele frequencies (MAF) ≤1 %; and (4) removing SNPs with HardyWeinberg Equilibrium (HWE) test with P < 10 −6 . For the SNP pairs to be tested, we also required (1) sample size of each of the nine two-SNP combinations greater than 20 in the discovery analysis and greater than 10 in the validation study; and (2) LD measure of r 2 < 0.1 between the two candidate SNPs. When necessary, untyped SNPs were imputed using IMPUTE2 [32] with HapMap3 [33] and 1,000 Genomes [34] reference haplotypes, which resulted in about the same set of SNPs across the three studies. No imputation was performed in MESA HA samples due to lack of appropriate reference haplotype panels. SNPs with information scores <0.6 were excluded, and each genotype was imputed to be the genotype with the highest posterior probability. When the highest posterior probability is less than 0.8, the genotype was treated as missing.
Four quantitative lipid measurements, total cholesterol (TC), LDL cholesterol (LDL-C), triglyceride (TG), and HDL cholesterol (HDL-C), were considered in the analysis. Each lipid level is measured at multiple time points and the average level per individual was used in all studies. A log transformation was applied to TG levels to normalize its distribution because of the skewness in the original distribution. Individuals self-reported to be taking lipidlowering medications were excluded. Sex, age, age squared, body mass index (BMI) were included as covariates in all analyses. The average values for age, age squared, and BMI were also used whenever multiple measurements were available. Plate number is also included as a covariate factor in the ARIC data due to its correlation with some of the lipid levels (known as "plate effect"). 
Test of Statistical Interactions
Two linear models were fitted and compared for testing of interaction. The first model (M1) included additive and dominance effect terms for each of the two SNPs without including any interaction effects between the two SNPs. The second model (M2), on top of M1, allows for four classic forms of epistatic interactions (additive × additive, additive × dominance, dominance × additive, and dominance × dominance), as follows: 
Here, β 0 is a vector of the intercept and possible nongenetic covariates; a i and d i are the additive and dominance effects of the ith SNP; and i aa , i ad , i da , and i dd denote the four classic interaction effects between the two SNPs. The existence of an epistatic interaction of any combination of the four types was tested by an F-test comparing M1 and M2 with four degrees of freedom [6, 35] . This classical test of statistical interactions is similar to the "--epistasis" option in PLINK [36] , except that only additive effects and additive × additive interactions are considered, such that an F-test with one degree of freedom is performed in PLINK. We note that the power of this test is strongly impacted by the marginal SNP allele frequencies. Potential population stratification was corrected using the principal component (PC) approach and the familial relationship in FHS was accounted for using a mixed model approach [22, 37] . PC analysis was conducted using EIGENSOFT [37] and the top ten PCs were included in the analysis as covariates to account for population stratification in ARIC and MESA samples. For FHS, a mixed model approach was first applied to account for familial relatedness and then pairwise interaction was tested on the residuals from the mixed models [22] .
We sought to validate (replicate) the interactions detected in the discovery study using data from FHS, MESA, and another AA sample from the ARIC study. "Validate" rather than "replicate" was used here because linked and proximate SNPs were included in the validation in addition to the original SNPs, as follows. For a significant interaction between two SNPs (e.g., A and B) in the discovery study, we performed the following possible stages of tests in the validation study: (1) Test for interaction directly between SNP A and SNP B; (2) If the interaction is not significant in stage (i), test for interactions between SNP A and each SNP less than 200 kb away from SNP B, and, similarly, between SNP B and each SNP surrounding SNP A; (3) If no test in stage (ii) is significant following multiple-testing correction, test for interactions between each SNP less than 100 kb away from A and each SNP less than 100 kb away from B. Assume there are n 1 and n 2 SNPs,
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respectively, surrounding SNPs A and B and the number of statistical tests to be conducted is 1, n 1 + n 2 , and n 2 in the three validation stages, respectively. To reduce the number of tests and the cost of multiple-testing correction on power, the validation process proceeds sequentially and stops at any stage where significant results were found after multiple-testing correction.
Though only pairwise interactions are considered, the total number of possible interaction tests across 2.5 million SNPs is still huge, at more than 3 × 10 12 tests. Due to the severe reduction in power entailed by stringent multiple-testing correction for such a large number of tests, it is crucial to restrict the total number of tests for the whole study. Therefore, through the following three strategies, we aimed to reduce the total number of interaction tests and to enrich interaction signals in the tests considered.
Recently, 95 genetic loci were associated with TC, LDL-C, TG, or HDL-C in a GWAS meta-analysis [7] . We considered 125 SNPs, previously associated with lipid levels [7] , in the 95 loci and tested each pair of SNPs on TC, LDL-C, TG, and HDL-C in the discovery sample of 9,713 EAs from the ARIC study. Using this approach, we tested ~7,748 pairwise interactions for each trait. We identified one significant interaction affecting LDL-C levels and one interaction on HDL-C. The interaction on LDL-C was between rs2247056 and rs1030431 (P c = 0.03 after Bonferroni correction). Both rs2247056 and rs1030431 were marginally associated with LDL-C, TG, and TC [7, 38] . We then performed fine mapping analyses on the loci surrounding the two SNPs to find the most significant interaction between rs2853928 and rs1993453 (P c = 0.01). We tried to validate the interaction on LDL-C in additional replication samples from ARIC, FHS, and MESA, but had no success.
The interaction on HDL-C was between rs12916 and rs1532085 (P c = 0.008) in the discovery study and was successfully validated in the replication samples (Table 1) . To further explore the interaction between the two loci, we tested interactions between each SNP surrounding rs12916 and each SNP surrounding rs1532085 within 100 kb. While many of these SNP pairs show significant interactions due to LD, the strongest signal was between rs3846662 and rs2043085 (P c = 0.002). SNP rs3846662, located in the intron of gene HMGCR, has been previously associated with TC and LDL-C [7, 39] , but not with HDL-C. Rs3846662 has also been associated with a 2.2-fold change in HMGCR expression in vitro [40] and alternative splicing of exon 13 [41] . The other SNP, rs2043085, has been found to be marginally associated with HDL-C [7] . Rs2043085 is located upstream of LIPC and is associated with the expression of the gene [6] . On top of marginal effects, interaction between the two SNPs affects HDL-C twice as much as the effect of LIPC alone. Table 1 Significant On average, individuals with the TT genotype at rs2043085 show an increase of 2.63 mg/dl in HDL-C; subjects with TT at rs2043085 and AA at rs3846662 exhibit an average increase of 5.72 mg/dl. The linear model with these two SNPs and their interaction has an r 2 value of 0.8 %, meaning that these two SNPs and their interaction combined to explain 0.8 % of phenotypic variation in HDL-C. Using the locus-based validation procedure, the interaction between rs3846662 and rs2043085 on HDL-C was successfully validated in stage (ii) for MESA EA samples and in stage (iii) for FHS EA, MESA HA, and ARIC AA cohorts (Table 1) . It did not validate after multiple-testing correction for the MESA AA sample, due to smaller sample size.
Prioritize SNP Pairs Using Biological Knowledge

Lipid GWAS Results
Over 3,000 high-confidence human PPIs were carefully assembled [42] . For each gene pair indicated by a PPI, we exhaustively tested all pairwise interactions between each SNP in the first gene and each SNP in the second gene. To map SNPs to genes, gene information (hg18) was obtained from the UCSC genome browser [43] and we considered all SNPs located between 5 kb upstream and downstream of a gene. Suppose there are n 1 and n 2 SNPs in the first and second genes, respectively, the number of possible pairwise interactions is n 1 × n 2 . For each of the four lipid traits, we performed ~6 million pairwise interaction tests according to the 3,000 PPIs, which resulted in no significant interactions following multiple-testing correction.
We hypothesized that possible gene-gene interactions are enriched between genes in the lipid-related pathways. To test this hypothesis, we used the metabolic pathway of lipids and lipoproteins as an example. There are a total of 228 genes in this pathway [44] and 12,716 SNPs are mapped to the 228 genes. We tested all pairwise interactions among the 12,716 SNPs, resulting in a total of ~27 million interaction tests for each lipid trait. Hence, it is not surprising that we found nothing significant after multiple-testing correction. However, there is a deviation in the QQ plot of the P values for interactions underlying TC levels. The interaction between rs4804546 and rs914196 is the strongest, though not significant following correction for the ~27 million tests (P c = 0.14). The interaction is between two genes, CARM1 and AGPAT3, from the metabolism of lipids and lipoproteins pathway. Gene AGPAT3 has been associated with phospholipid levels [45] , and CARM1 has not been associated with any lipid levels.
Notes
To ensure accuracy and power, quality control process is of crucial importance in genetic association studies, as well as in studies of epistasis [46, 47] . Non-normality distribution and outliers of the quantitative phenotype can potentially lead to false positive results
Protein-Protein Interactions (PPIs)
Lipid Pathway Information
with very small P values, particularly when individuals carrying the minor multi-SNP genotype incidentally are also outliers of the phenotype. When both outliers and low-frequency SNPs exist in the data, the chance of false positives can be inflated. Therefore, a minor multi-SNP genotype frequency filter (20 in discovery and 10 in validation in this study) is necessary when testing for interactions, much like the MAF filtering in a typical GWAS quality control.
While the interaction we identified was replicated in multiethnic populations, it still has a moderate effect size, which is approximately the same magnitude as the marginal effect discovered in GWAS for lipid traits. If this is the case for general epistatic interactions, we will have a lower power for detecting epistasis than marginal associations, which also explains why so few interactions have been detected and replicated in human GWAS. Moreover, unfortunately, epistatic interactions with such small effect sizes may only explain a minor proportion of the missing heritability, unless as some argue, there are a great many weakly interacting pairs.
Note that the interaction we detected in this study was validated in part by proximate SNPs, thus indicating the power of integrating information from genomic regions surrounding target SNPs, like a gene-based test for marginal associations. Recently, a series of gene-based interaction testing methods have been developed in the literature [48] [49] [50] [51] [52] , which can be employed to increase power of detecting and replicating gene-gene interactions.
In summary, we detected significant interactions after multipletesting correction only in <10k tests guided by GWAS, but found nothing significant in 6 and 27 million tests using PPI and pathway information, respectively. By noticing that the study is already powerful with a sample size of over 10,000, multiple measurements of phenotypes, and a genome-wide one million SNPs, we only afford to perform <10k tests to be able to identify the significant gene-gene interactions from false positives. In conclusion, a small-scale, biological, knowledge-driven study with higher enrichment of putative signals may hold the key to identifying gene-gene interactions underlying complex diseases or traits in current and future association studies.
